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Abstract Multidrug resistant strains of Staphylococcus aureus
are a major cause of skin and soft tissue infections requiring the
development of novel and alternative therapeutic options. Pho-
todynamic oxidation is the cornerstone of antimicrobial photo-
dynamic therapy (aPDT) involving the combined use of light and
a photosensitizer, which, in the presence of oxygen, originates
cytotoxic species capable of oxidizing biological molecules and
leads to inactivation of target cells. We have previously shown
that susceptibility to aPDT differs significantly across S . aureus
isolates and could be associated with several genetic elements.
However, the effect of the photodynamic process regarding the
S . aureus genetic background has never been reported. We have
compared the genetic backgrounds of the strains (SCCmec types,
spa types and main clonal complexes) with respect to their
susceptibility to protoporphyrin IX-mediated photodynamic in-
activation. SCCmec typing revealed no differences in response
to photoinactivation. However, detection of spa types and clonal
complexes clustered the studied population of MRSA strains
according to their response to photodynamic oxidation. Clonal
complex 1 (CC1) accounted for elevated resistance and CC30
(ST36) for susceptibility to photoinactivation. Moreover, spa
typing identified isolates resistant (t032) and susceptible to pho-
todynamic oxidation (t051, t015). The very tight association
between clonal lineages and response to photodynamic inactiva-
tion indicates the important role of genetic background for aPDT
efficacy. These results make a case for the development of a
diagnostic tool with the predictive value of aPDT efficacy ac-
cording to an identified genetic background of S. aureus isolates.
Introduction
Healthcare-associated infections, especially those caused by
methicillin-resistant Staphylococcus aureus strains (HA-
MRSA), are a great danger to both hospitalized and immuno-
compromised patients, in whom the organism causes high mor-
bidity and mortality [1]. S . aureus displays extensive genetic
variability. Genotyping analyses, such as multilocus sequence
typing (MLST) and protein A (spa) sequence typing, demon-
strated that the S . aureus population structure is highly clonal
with sixmajor clonal complexes (CCs) (CC1, CC5, CC8, CC22,
CC30, and CC45) [2–4]. Most mobile genetic elements can
readily spread horizontally among S . aureus strains of the same
clonal cluster, while transfer between clusters is limited. S .
aureus strains are generally classified into two classes according
to their resistance toβ-lactam antibiotics: methicillin-sensitive S .
aureus (MSSA) andMRSA strains. One of the resistance mech-
anisms to β-lactams used by MRSA is based on the production
of an alternative penicillin-binding protein (PBP) encoded by the
mecA gene; this protein is termed PBP2a. InMRSA, exposure to
β-lactams inactivates the four high-binding-affinity PBPs nor-
mally present. PBP2a, which displays a low affinity for β-
lactams, takes over the functions of these PBPs, permitting the
cell to grow. The mecA gene is located on a mobile genetic
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element integrated into the bacterial chromosome and called the
staphylococcal cassette chromosomemec (SCCmec) [5]. Eleven
different types of SCCmec , assigned SCCmec I to SCCmec XI,
have been defined so far. Most epidemiological investigations
focus on types I to VI, and studies on SCCmec types VII to XI
are rarely reported [6–9]. This genetic element is widely used for
the determination of MRSA clones. Identification of SCCmec
type can be used to predict strain origin, as the majority of
nosocomial isolates harbor SCCmec I, II, or III, whereas
community-associated MRSA strains (CA-MRSA) are charac-
terized by SCCmec IVand V [8–10]. Furthermore, it seems that
SCCmec element is involved in staphylococcal virulence. It has
been shown that SCCmec type-associated virulence factors sub-
stantially influence the progression of staphylococcal bacter-
emia, and SCCmec II S . aureus strains cause the highest mor-
bidity among hospitalized patients [11]. Thus, the determination
of SCCmec types, clonal complexes, or spa types may have an
important diagnostic value. Whilst no single typing method
meets all the requirements for typing techniques, there have been
recent trends toward the use of spa , MLST, and SCCmec
methods [12]. Large typing databases and networks have been
developed to handle the data. The spa typingmethod is based on
sequencing of the polymorphic X region of the protein A gene
(spa), present in all strains of S . aureus . TheX region consists of
a variable number of 24-bp repeats flanked by well-conserved
regions. This single-locus sequence-based typing method com-
bines a number of technical advantages, such as rapidity, repro-
ducibility, and portability. Moreover, because of its repeat struc-
ture, the spa locus simultaneously indexes micro- and
macrovariations, enabling the use of spa typing in both local
and global epidemiological studies [13]. The current terminology
to describe a lineage is based on multilocus sequence typing
(MLST) clonal complexes (CCs). MLST involves sequencing
seven housekeeping genes and assigning a sequence type (ST)
number to isolates that are identical [12].MLST is recommended
for use in regional laboratories and is a useful tool for defining
lineages and scientific analysis. These methods, plus SCCmec ,
provide the minimum requirements for appropriate molecular
epidemiology [12].
The antimicrobial photodynamic therapy (aPDT) has
gained increasing importance because of its ability to eradicate
a broad spectrum of pathogenic microorganisms [14, 15]. In
the clinical area it could be a potential alternative to the
antibiotics used to treat staphylococcal infections. The photo-
dynamic process involves the combined use of light, molecu-
lar oxygen, and a photosensitive compound (photosensitizer)
[16]. This interaction leads to production of reactive oxygen
species and free radicals responsible for oxidation of many
biological molecules (enzymes, proteins, lipids, and nucleic
acids), leading to cell death [17]. Additionally, the resistance
mechanisms towards photodynamic inactivation have not yet
been observed [18, 19]. However, our studies of the
photoinactivation (PDI) of multiresistant pathogenic bacteria
have shown that the effectiveness of PDI is strain-dependent
and that one should search for possible strategies to overcome
resistant phenotype, but, on other hand, to develop the diag-
nostic tool clustering strains according to their susceptibility to
PDI [20–24]. The mechanism underlying this phenomenon is
still poorly understood. Thus, by applying SCCmec typing
and collecting the isolates representing different spa geno-
types and clonal clusters, we aimed, in particular, to assess the
contribution of the bacterial genetic background in S . aureus
response to photodynamic oxidation.
Materials and methods
Bacterial isolates
In total, 438S . aureus strains (418 MRSA and 20 MSSA)
were used. Of them, 321 clinical MRSA strains were isolated
between 2002 and 2012 at the Provincial Hospital in Gdansk
and Hospital in Koszalin (Poland) and were previously char-
acterized. The isolates were characterized by Gram staining
and the ability to produce coagulase and the clumping factor
using Slidex Staph Plus (bioMèrieux, France) and were re-
identified to the species level using the MALDI-TOF MS
(Bruker Daltonics, Germany). Methicillin resistance was de-
termined using a disc-diffusion method as well as a latex test
detecting PBP2a protein (Staphytect Plus; Oxoid, Lenexa,KS,
USA) [25]. Of the 321 strains collected, 40.5 % (130 isolates)
were isolated from surveillance cultures, 46.4 % (149 isolates)
from patients with local infections, 11.8 % (38 isolates) from
patients with bacteremia and generalized infections and 1.3 %
(4 isolates) from infections connected with endoprostheses.
An additional 97 MRSA and 20 MSSA isolates, with identi-
fied CCs and spa type were obtained through the Network of
Antimicrobial Resistance in Staphylococcus aureus
(NARSA), Staphylococcus Laboratory, Statens Serum Insti-
tute in Denmark, Centre for Clinical Infection and Diagnostics
Research in the UK, University of Oviedo in Spain, and
National Medicines Institute in Poland. The strains are listed
in Online Resource 1. Clonal complexes (CC) were deter-
mined with the use ofMLST. All clonal complexes, excluding
CC8, were represented by single ST. CC8 included strains
with ST8 and ST247. Additionally, the reference strains of S .
aureus listed in Table 1 were used to optimize SCCmec type
determination. The abundance of S . aureus isolates in each
group is provided in Table 2. The molecular characteristics of
isolates are provided in Table 3.
MALDI-TOF MS
Three hundred and twenty-one S . aureus clinical strains iso-
lated from hospitals in Poland were examined by MALDI-
TOF MS using a Microflex LT instrument (Bruker Daltonics,
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Leipzig, Germany), Flexcontrol 3.0 software and the Biotyper
2.0 database (Bruker Daltonics, Germany). The data analysis
was performed according to the manufacturer’s instructions.
The samples were covered with 1 ml matrix solution (a
saturated solution of a-cyano-4-hydroxycinnamic acid in
50 % acetonitrile, 2.5 % trifluoroacetic acid). The analyzed
mass range of spectra was 2,000–20,000 m/z. Each spectrum
was obtained after 240 shots in an automatic acquisition
mode. For the identification approach, a mass-to-charge range
of 3,000–15,000Dawas used. Identificationwas performed in
duplicate and the higher score was retained. The identification
score cut-off values were applied on each measurement ac-
cording to the manufacturer’s instructions. According to this
score system, a score of<2 is recommended for a probable
species and a score of greater than 2.3 is recommended for a
secure species identification [26].
Nucleic acid isolates
For DNA isolation, strains were grown overnight in nutrient
trypticase soy broth (TSB) (bioMèrieux, France) at 37 °C for
24 h. Then, 1.5 ml of the bacterial culture was centrifuged at
5000 x g for 10 min. The pellet was suspended in 180 μl of
lysis buffer (20 mM Tris–HCl, pH 8.0, 2 mM EDTA, 1.2 %
Triton X-100, lysozyme 20 mg/ml) and the GeneJET™ Ge-
nomic DNA Purification Kit (Thermo Scientific, Vilnius,
Lithuania) was used for DNA isolation according to the man-
ufacturer’s procedure. The DNA concentrations were mea-
sured using NanoDrop ND-1000 (Thermo Scientific) and
were within the range 10 to 100 ng/μl. In addition, the quality
of the isolated DNAwas confirmed by gel electrophoresis.
SCCmec type-specific multiplex PCR
A two-tube multiplex PCR method was performed to identify
the SCCmec types from the MRSA isolates [27]. One tube
Table 2 Distribution of methi-
cillin-resistant Staphylococcus
aureus (MRSA) isolates by typ-
ing procedures
a Only types represented by more
than three isolates were included





























Table 1 Primers and reference strains used in the study
Strain used as standard Primer Oligonucleotide sequence (5′–3′) Size (bp) Reference
NCTC 10442 SCC I Forward: GCT TTA AAG AGT GTC GTTACA GG
Reverse: GTT CTC TCATAG TAT GAC GTC C
613 [27]
N315 SCC II Forward: GAT TAC TTC AGA ACC AGG TCAT
Reverse: TAA ACT GTG TCA CAC GAT CCAT
287 [27]
85/2082 SCC III Forward: CAT TTG TGA AAC ACA GTA CG
Reverse: GTTATT GAG ACT CCTAAA GC
243 [27]
8/6-3P SCC IVb Forward: AGTACATTT TAT CTT TGC GTA
Reverse: AGT CAT CTT CAATAT GGA GAA AGTA
1,000 [27]
81-108 SCC IVc Forward: TCTATT CAATCG TTC TCG TAT T
Reverse: TCG TTG TCATTTAAT TCT GAA CT
677 [27]
JSCS 4469 SCC IVd Forward: AAT TCA CCC GTA CCT GAG AA
Reverse: AGA ATG TGG TTATAA GATAGC TA
1,242 [27]
WIS SCC V Forward: GAA CAT TGT TAC TTA AAT GAG CG
Reverse: TGA AAG TTG TAC CCT TGA CAC C
325 [27]
NCTC 10442 Sa442 Forward: AAT CTT TGT CGG TAC ACG ATATTC TTC ACG
Reverse: CGTAAT GAG ATT TCA GTA GATAATACA ACA
108 [27]
NCTC 10442 mecA Forward: TCC AGATTA CAA CTT CAC CAG G
Reverse: CCA CTT CATATC TTG TAA CG
162 [27]
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was used to determine SCCmec types I, II, III, and V, and one
tube was used to determine SCCmec types IVa, IVb, IVc, IVd,
and IVh. In the first reaction, the Sa442 andmecA genes were
also amplified as a control. Sa442 is a gene specific to S .
aureus , and mecA encodes the alternate penicillin-binding
protein responsible for beta-lactam resistance. The two-tube
reactions were performed in a 25-μl reaction mixture contain-
ing 4 μl of the purified nucleic acid solution, 1 U of
DyNAzyme™ EXT Taq DNA Polymerase (Thermo Scientif-
ic), 10X DyNAzyme™ EXT Buffer (Thermo Scientific),
200 μM dNTPs (MetaBion, Martinsried, Germany), and
SCCmec group-specific primers. For the first tube reactions,
a 2-μM concentration of SCC I primers were used along with
a 0.4 μM concentration of the primers for mecA , Sa442 , SCC
II, SCC III, and SCC V (primers listed in Table 1). For the
second tube reactions, 2 μM concentrations of the primers for
SCC IV were used (primers listed in Table 1). Amplifications
were performed in an Applied Biosystems thermocycler
program: 1 cycle of 4 min at 95 °C; 30 cycles of 30 s at 94 °C,
1min and 30 s at 57 °C, 1min and 30 s at 72 °C, and a final cycle
of 10 min at 72 °C. Amplification products were electrophoresed
in a 1.8 % agarose gel (BIORON, Ludwigshafen, Germany)
containing ethidium bromide and visualized by transillumination
(Gel Doc 2000; Bio-Rad) under UV irradiation [27].
Photosynthesizer
Protoporphyrin IX (PPIX) (MP Biomedicals, LLC, USA) was
used as a sensitizer. PPIX was dissolved in dimethyl sulfoxide
(DMSO; Sigma, Germany) to make a 1-mM stock solution and
was stored in the dark at −20 °C until use. The concentration of
the photosensitizer was determined spectrophotometrically (ex-
tinction coefficient 1.6 x 105 M−1 cm−1, wavelength 408 nm).
Light source
PDI studies
Three hundred and twenty-one isolates were already charac-
terized regarding their response to photodynamic inactivation.
One hundred and seventeen newly collected S . aureus strains
(97 MRSA and 20 MSSA isolates) were subjected to photo-
dynamic inactivation (PDI). Bacterial cultures were grown
overnight (24 h) at 37 °C in nutrient trypticase soy broth
(bioMèrieux, Craponne, France) and then diluted with fresh
broth to an appropriate density (107/ml bacterial cells) based
on densitometry (Densi Meter II, EMO). Diluted S . aureus
cultures were incubated with 25 μM protoporphyrin IX in the
dark at 37 °C for 30 min. The cells were then transferred to a
96-well microtiter plate (100 μl per well) and illuminated with
appropriate light (50 J/cm2) at room temperature for 8 min and
10 s. Following illumination, 10 μl aliquots were used to
Table 3 Molecular characteris-
tics of MRSA isolates
ND not determined
Typing procedure (No. of isolates)
CC ST SCCmec type spa type
CC1 (5) ST1 (5) IV (5) t125 (1), t128 (2), t175 (2)
CC5 (22) ST5 (22) II (21) IV(1) t002 (15), t010 (2), t062 (2)
t088 (1), t242 (1), t601 (1)
CC8 (16) ST8 (16) I (3) II (1) IV (12) t008 (7), t024 (1), t064 (6)
t2238 (1), t451 (1)
ST247 (9) I (5) IV (4) t051 (6), t052 (2), t770 (1)
CC22 (8) ST22 (8) IV (8) t005 (1), t032 (6), t852 (1)
CC30 (3) ST36 (3) II (3) t018 (2), t253 (1)
CC45 (34) ST45 (34) II (1) III (1) IV (31) V (1) t015 (12), t026 (4), t040 (1)
t050 (3), t065 (1), t1078 (1)
t1081 (1), t1574 (1), t230 (4)
t2135 (1), t330 (1), t350 (1)
t445 (1), t583 (1), t620 (1)
ND ND I (21) II (203) III (20) IV (61) V (16) ND
97 97 418 97
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(GeneAmp® PCR System 9700) using the following temperature
Illumination was performed using a Q.Light® PDT Lamp (b
& p® Schweiz AG, St Gallen, Switzerland) (ISO 9001 and EN
46001—CE 1275; power of lamp 80 mW; fluence rate
102 mW/cm2; fluence 6.12 J/cm2 per minute). The delivered
light energy was determined with the use of a light power
meter (model LM1; Carl Zeiss, Oberkochen, Germany). The
Q.Light® PDT Lamp emits polarized light (polarization level:
98 %) over a wavelength range of 620 to 780 nm.
determine the colony forming units (CFU). The contents of
the wells were mixed before sampling, and the aliquots were
serially diluted 10-fold in PBS (0.13 mM NaCl, 8.1 mM
Na2HPO4, 2.68 mMKCl, 1.47 mMKH2PO4) to achieve final
dilutions of 10−1 to 10−4, which were then streaked horizon-
tally onto square trypticase soy agar plates [28]. The plates
were incubated at 37 °C overnight. Controls consisted of
untreated bacteria (no photosensitizers or light) kept in 96-
well plates for the duration of the illumination. After 18 h of
incubation at 37 °C in the dark, CFUs were counted and the
results were statistically analyzed. Survival fractions were
expressed as ratios of CFUs of treated bacteria (with light
and photosensitizer) to CFUs of untreated bacteria. The ex-
periment was performed three times.
Statistical analysis
The statistical analyses have been performed using the statis-
tical suite StatSoft (2011) Statistica (data analysis software
system) version 10.0. www.statsoft.com and Excel. The
quantitative variables were characterized by the arithmetic
mean of standard deviation or median or maximum/
minimum (range) and 95 % confidence interval. The qualita-
tive variables were presented with the use of count and per-
centage. Statistical significance of differences between two
groups (unpaired variables model) was processed with the
Student’s t test. The significance of difference between more
than two groups was assessed using F test (ANOVA). In all the
calculations the statistical significance level of p <0.05 has
been used.
Results
Heterogeneous response of S . aureus to PDI
The different strains expressed a heterogeneous response to
photoinactivation, ranging from 0 to 4.51 log10-unit reduc-
tions in viable counts under the same experimental conditions.
According to lethal or sub-lethal damage caused by PDI
treatment, the strains were classified as sensitive or resistant
PDI responders (cut-offs for the categorization presented in
Table 4). Strains revealing reduction in viable counts ranged
between lethal and sub-lethal damage were assigned as
intermediate-sensitive (Table 4).
The SCCmec element does not have an impact on PDI
response
To determine if any relationship exists between the PDI re-
sponse and the type of SCCmec , SCCmec typing was per-
formed for 321 clinical MRSA strains (for the rest of the 97
isolates SCCmec types had already been characterized). The
results showed that for the MRSA strains studied, the distri-
bution of PDI responders among the five different groups
classified according to SCCmec types is similar (Fig. 1).
The same conclusion could be drawn when comparing the
distribution of uncategorized values of responses to PDI
across S . aureus groups with different SCCmec types
(Fig. 2). We can therefore conclude that the type of SCCmec
element has no impact on the strain’s response to PDI and
could not classify strains according to their response to pho-
todynamic treatment.
Susceptibility to photodynamic oxidation and clonal complex
Four-hundred eighteen MRSA isolates varied in their re-
sponse to photodynamic inactivation. The results showed that
for the MRSA strains studied, the distribution of PDI re-
sponders among the seven different groups classified accord-
ing to clonal complex is different (Fig. 1). Interestingly, all
CC1 S . aureus strains (n =5) were identified as PDI-resistant
isolates. Conversely, all CC30 isolates (n =3) were character-
ized as PDI-sensitive or -intermediate-sensitive strains
(Fig. 1). Also, the percentage of CC45 isolates increased in
accordance with susceptibility to photoinactivation (Fig. 1;
not statistically significant analysis). When analyzing the un-
categorized values of response to PDI, clonal complex typing
revealed significant differences in S . aureus response accord-
ing to its genetic background (Fig. 3). Strains belonging to CC1
showed strict association with resistance to photoinactivation,
whereas CC30 and CC8 (ST247) isolates were in general sus-
ceptible to PDI (Fig. 3). As different behavior was observed for
strains CC8 according to their STs, ST number was provided in
parenthesis (ST8 and ST247 respectively). Number of isolates
representing each clonal complex is provided in Table 2. Results
obtained indicated possible association of CC-mediated determi-
nation of genetic background and susceptibility to photodynamic
oxidation.
Susceptibility to photodynamic oxidation and spa types
Determination of genetic background with spa typing also
indicated its association with susceptibility to photodynamic
Table 4 Range of effectiveness of photosensitization of MRSA isolates
log10-unit reduction Classification
a Number of isolates (%)
0–0.99 Resistant 253 (60.50)
1–1.99 Intermediate-sensitive 111 (26.55)
2–4.51 Sensitive 54 (12.95)
Total 418 (100.0)
a Categorization made owing to lethal and sub-lethal damage caused by
photoinactivation
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inactivation as statistically different PDI responses were ob-
served in respect of spa types (Fig. 4). Interestingly, spa
typing led to distinguishing the CC45 cluster into PDI-
sensitive and -intermediate-sensitive strains. When analyzing
solely the clonal complex, isolates belonging to CC45 gener-
ally showed intermediate sensitivity to photodynamic treat-
ment (Fig. 3). When applying spa typing, the differentiation
of PDI-sensitive strains was observed (t015) (Fig. 4). This spa
type was detected exclusively within CC45 (Table 3). The
analyses of distribution of PDI responders across different spa
types also revealed that the percentage of t015 and t051
isolates increased in accordance with susceptibility to
photoinactivation (Fig. 1). Conversely, the percentage of
t064 isolates increased in accordance with resistance to PDI
(Fig. 1). These observations indicated the possible association
of genetic background of S . aureus isolates with susceptibility
to photodynamic oxidation (not statistically significant
analysis).
Fig. 1 Distribution of methicillin-resistant Staphylococcus aureus (MRSA) S. aureus clusters (staphylococcal cassette chromosome (SCC)mec types, clonal
complexes and spa types) in photoinactivation (PDI) categories. R PDI-resistant strains, IS PDI-intermediate-sensitive strains, S PDI-sensitive strains
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Similar PDI response across MRSA and MSSA strains
belonged to CC22 and CC45
To investigate whether the same susceptibility and/or resistance
to photoinactivation could be observed in S . aureus isolates
regardless of MRSA or MSSA status, the PDI response was
analyzed in MRSA and MSSA isolates belonging to the same
genetic background. Interestingly, the response of CC22 and
CC45 S . aureus isolates was the same in theMRSA andMSSA
groups indicating that the associations observed are indepen-
dent of presence of SCCmec element (Fig. 5).
Discussion
Recently we demonstrated that a strain-dependent response of
S . aureus to PDI exists, although the underlying mechanism
remains unexplained [22, 23, 29]. The current study aimed to
investigate statistically relevant correlations between the ge-
netic backgrounds of methicillin-resistant S . aureus strains
and their response to photodynamic inactivation. Thus,
Fig. 2 Response to protoporphyrin IX (PPIX)-mediated PDI of S . aure-
us strains with various types of SCCmec element. Each box plot repre-
sents the spread of bacterial response across different clinical isolates. The
error bars represent minimum and maximum values of log10-unit reduc-
tion in viable counts
Fig. 3 Response to PPIX-mediated PDI of S . aureus strains from various
clonal complexes. Each box plot represents the spread of bacterial re-
sponse across different clinical isolates. The error bars represent mini-
mum and maximum value of log10-unit reduction in viable counts
Fig. 4 Response to PPIX-mediated PDI of S . aureus strains with various
spa types. Each box plot represents the spread of bacterial response
across different clinical isolates. The error bars represent minimum and
maximum value of log10-unit reduction in viable counts
Fig. 5 Response to PPIX-mediated PDI of MRSA and MSSA strains
belonging to the same clonal clusters. Each box plot represents the spread
of bacterial response across different clinical isolates. The error bars
represent minimum and maximum value of log10-unit reduction in viable
counts
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evaluation of response to photodynamic treatment in distinct
clonal lineages of S . aureus was performed.
It might be concerning that the concentration of DMSO
used in the experiments could affect the results obtained.
Ghajar and Harmon [30] studied the influence of DMSO on
the permeability of S . aureus , demonstrating that DMSO
increased the oxygen uptake, but reduced the rate of glycine
transport. DMSO exerts a marked inhibitory effect on a wide
range of bacteria and fungi. For S . aureus , the minimal
inhibitory concentrations of DMSO vary between 20 and
30 % and minimal bactericidal concentrations are above
30 % [31]. 2.5 % DMSO (used in the current study) is not
lethal but is high enough to possibly alter membrane perme-
ability depending on the surface protein concentration [30,
32]. To exclude the possible impact of DMSO on PPIX
uptake, the intracellular concentration of DMSO-soluble
PPIX and water-soluble PPIX derivative (protoporphyrin
diarginate, PPArg2) was measured after 30 min incubation at
37 °C. The level of PPArg2 uptake was measured previously
[33]. The intracellular uptake of both PPIX and PPArg2 was
similar (35 vs 38 μg per mg of bacterial protein) indicating
that 2.5 % DMSO did not affected the intracellular uptake of
sensitizers [33]. It is worth emphasizing that photodynamic
treatment including porphyrin derivatives sensitizers, could
utilize DMSO concentrations of up to 25 %, revealing that
the 2.5 %DMSO used in the current study is in fact a very low
dose [34]. Thus, we can conclude that the differences ob-
served in S . aureus response to PPIX-mediated
photoinactivation are not affected by the 2.5 % DMSO used.
Previously, we have shown that MRSA strains were found
to have a generally higher percentage of PDI resistance than
MSSA strains [22]. This result suggested that PDI resistance
may be related to multidrug-resistance in MRSA strains, thus
prompting our investigation of the staphylococcal cassette
chromosome mec element. The data obtained during this
study allowed us to conclude that the SCCmec element has
no effect on the strain response to PDI, as there were no
statistically significant differences between SCCmec types
and the response to PDI. Thus, we can assume that the
observed phenomenon of a higher number of PDI-resistant
strains within the MRSA group is a secondary effect not
directly connected to antibiotic resistance. The same conclu-
sion could be drawn when comparing the susceptibility to PDI
in MRSA and MSSA groups belonging to the same clonal
complexes (Fig. 5).
Different SCCmec elements may be observed in virtually
identical genetic backgrounds, and conversely, strains from
completely different clonal complexes may acquire the same
SCCmec elements (Table 3) [35]. Thus, it was necessary to
further investigate the possible association of susceptibility to
PDI with clonal complexes or spa clusters. This study re-
vealed that elevated resistance of S . aureus to PDI could be
associatedwith clonal complex CC1 and observed in 100% of
these isolates. Furthermore, clustering the isolates into clonal
complexes and spa types led to identification of PDI-sensitive
S . aureus lineages. The most PDI-sensitive isolates were
characterized within CC30 and spa types t015 and t051.
However, one must remember that in the current study the
number of representatives in some spa types was too low to
draw statistically relevant conclusions and further investiga-
tions should be performed to indicate evidence-based
associations.
In summary, the present study revealed that particular
genetic backgrounds could be a predisposing factor for ele-
vated resistance to photodynamic treatment. Results of the
present study corroborate the potential of CC typing proce-
dure that could be applied to disclose the major lineages
represented in S . aureus collection and to detect the PDI-
resistant phenotypes. These can then be further identified
accurately by other powerful techniques, such as spa typing.
It is significant to underline that the resistance mechanisms
toward photodynamic inactivation have not yet been observed
[18, 19]. The phenomenon that is described within the current
paper concerns resistant phenotypes; thus, applying more
rigorous photodynamic conditions (like a higher light dose
or sensitizer concentration) this resistance could be overcome.
Nevertheless, it is clinically relevant to identify isolates re-
quiring stricter conditions to adjust the photoinactivation pro-
cedure ensuring a successful therapeutic effect. We believe
that enhanced investigation concerning the association of S .
aureus genetic background with susceptibility to photody-
namic inactivation could lead to precise identification of
PDI-resistant phenotypes. These studies should include more
numerous groups of clonal clusters with respect to clonal
complex and other spa types. Moreover, it is important to
make it clear that aPDT efficacy depends on the ability of the
photosensitizer and light to penetrate bacterial membranes;
thus, more studies must be carried out using other types of
sensitizing agents to prove the same behavior.
S . aureus infections continues to be a growing burden for
the healthcare system. The latest epidemiological data suggest
that this problem will continue to grow as the number of at-
risk patients rises. Moreover, antibiotic resistance spreads
from healthcare settings to the community and the develop-
ment of alternative therapeutic approach is needed. One of the
possibilities could be photodynamic inactivation; however, it
is also not without limitations. One is the existence of PDI-
resistant phenotypes that require more rigorous treatment
conditions to achieve the total eradication. To improve the
therapeutic outcome an effort is needed in prediction of isolate
response to photodynamic treatment including a better diag-
nostic of resistant phenotypes. The strategies to overcome
PDI-resistant phenotypes as well as mechanisms leading to
PDI resistance have been described elsewhere [21, 29, 36];
however, the impact of genotypic background on the suscep-
tibility of different strains to PDI remains unexplored and
584 Eur J Clin Microbiol Infect Dis (2014) 33:577–586
should be a field of great interest in the future as it could have
a significant clinical impact.
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